NCT01192958

Completed

A Study to Validate a New Oral Fluid/Saliva Antibody Test fo...

Public Health England Source

Compare

Other study identifiers

Sponsor study identifier

OFLU

Study Type

observational

Reported enrollment (type unavailable)

N/A

Locations

0 countries

Sites

N/A

Timeline

Study Start

January 2010

Date type not reported

This date has not been verified as actual or estimated.

Primary Completion

July 2010

Actual (reported)

Study Completion

July 2010

Actual (reported)

Brief Summary

At present influenza immunity can only be reliably confirmed by a blood test. This test is invasive for the patient. This study is intended to validate an oral fluid/saliva antibody test for the variant Swine Influenza H1N1. If such a test were available, this painless and non invasive test will improve direct clinical care to an individual as well as significantly help guide future public health management of the pandemic.

Registry Overview

Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.

Recruitment status: completed
Reported enrollment (type unavailable): Not reported
Study completion date: July 2010
Actual (reported)
Listed locations: 0 countries · 0 sites

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.

Study Start
January 2010
Date type not reported
This date has not been verified as actual or estimated.
Primary Completion
July 2010
Actual (reported)
Study Completion
July 2010
Actual (reported)
First Submitted
August 31, 2010
Actual (reported)
First Posted
September 1, 2010
Actual (reported)

Last Updated: September 1, 2010
Status Verified: December 2009
Last Update Submitted: August 31, 2010

Conditions

H1N1 Virus

Keywords

swine flunovel h1n1vnovel h1n1h1n1

Eligibility Criteria

Age6 Months+

Sexall

Healthy VolunteersYes

Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

Sampling MethodNon-Probability Sample

Study Population

Subjects from primary care who are participating in the clinical service evaluation.

You may qualify if:

Participants of the clinical service evaluation of novel H1N1v vaccine
First or second blood sample for the clinical service evaluation successfully collected

You may not qualify if:

Withdrawn from clinical service evaluation of novel H1N1v vaccine
Second blood sample for the clinical service evaluation not collected.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Public Health England
Governmentlead

MeSH Terms

Conditions

Orthomyxoviridae Infections

Condition Hierarchy (Ancestors)

RNA Virus InfectionsVirus DiseasesInfections

Study Design

Study Type: observational
Observational Model: CASE ONLY
Sponsor Type: OTHER GOV

Study Record Dates

First Submitted

August 31, 2010

First Posted

September 1, 2010

Study Start

January 2010

Date type not reported

This date has not been verified as actual or estimated.

Primary Completion

July 2010

Actual (reported)

NCT00989404

Crossover Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Repeat Dose Zanamivir/Placebo Via Devices Administered Twice Daily for 5 Days

Phase 1Completed

NCT00992017

Safety of and Immune Response to an H1N1 Influenza Vaccine in HIV Infected Pregnant Women

Phase 2Completed

NCT00992836

Safety of and Immune Response to an H1N1 Influenza Virus Vaccine in HIV Infected Children and Youth

Phase 2Completed

NCT01031719

Clinical Trial to Compare the Immunogenicity, Safety, and Tolerability of an Adjuvanted A(H1N1) Influenza Vaccine Versus Non-Adjuvanted A(H1N1) Influenza Vaccines in Patients With Invasive Solid Tumors

Phase 3Completed

NCT00973895

VRC 308: An Open-Label Phase I Study of the Safety and Immunogenicity of an Investigational H1 DNA Influenza Vaccine, VRC-FLUDNA057-00-VP, in Healthy Adults 18-70 Years Old

Phase 1Completed

NCT01032408

Immunogenicity, Safety, and Tolerability of MF59-Adjuvanted Versus Non-Adjuvanted Influenza Vaccines in Patients With HIV-1 Infection

Phase 3Completed

Study Completion

July 2010

Actual (reported)

Last Updated

September 1, 2010

Record last verified: 2009-12

Source record

Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.

Source: ClinicalTrials.gov.

JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.

Registry identifier: NCT01192958
Data provider: ClinicalTrials.gov
Source updated: 2010-09-01
Normalization version: ctgov-legacy-1

Open registry record

Source retrieved: 2026-10-25 22:21:02 UTC

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

Study Start

Primary Completion

Study Completion

First Submitted

First Posted

Conditions

Keywords

Eligibility Criteria

You may qualify if:

You may not qualify if:

Sponsors & Collaborators

MeSH Terms

Conditions

Condition Hierarchy (Ancestors)

Study Design

Study Record Dates

Source record